eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2024
vol. 49
 
Share:
Share:
Clinical immunology

High mobility group box protein 1 sensitizes mononuclear cells to further contact with lipopolysaccharide

Jakub Piotrowski
1
,
Tomasz Jędrzejewski
2

1.
Department of Health Psychology, Faculty of Psychology, Kazimierz Wielki University, Bydgoszcz, Poland
2.
Department of Immunology, Faculty of Biological and Veterinary Sciences, Nicolaus Copernicus University, Torun, Poland
Cent Eur J Immunol 2024; 49 (1): 52-59
Online publish date: 2024/04/19
Article file
- High mobility group.pdf  [0.25 MB]
Get citation
 
PlumX metrics:
 
1. Beisel WR (1999): Overview of the immune system and other host defense mechanisms. In: Institute of Medicine (US) Committee on Military Nutrition Research. Military Strategies for Sustainment of Nutrition and Immune Function in the Field. National Academies Press, Washington (DC). Available from: https://www.ncbi.nlm.nih.gov/books/NBK230976
2. Piotrowski J, Jędrzejewski T, Pawlikowska M, et al. (2019): High mobility group box 1 protein released in the course of aseptic necrosis of tissues sensitizes rats to pyrogenic effects of lipopolysaccharide. J Therm Biol 84: 36-44.
3. Martinotti S, Patrone M, Ranzato E (2015): Emerging roles for HMGB1 protein in immunity, inflammation, and cancer. Immuno Targets Ther 4: 101-109.
4. Lotze MT, Tracey KJ (2005): High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5: 331-342.
5. Marjanac I, Lovrić R, Barbić J (2019): Serum levels of the high-mobility group box 1 protein (HMGB1) in children with type 1 diabetes mellitus: case-control study. Cent Eur J of Immunol 44: 33-37.
6. Yang H, Wang H, Chavan SS, Andersson U (2015): High mobility group box protein 1 (HMGB1): the prototypical endogenous danger molecule. Mol Med 21: 6-12.
7. Lee SA, Kwak MS, Kim S, Shin JS (2014): The role of high mobility group box 1 in innate immunity. Yonsei Med J 55: 1165-1176.
8. Hori O, Brett J, Slattery T, et al. (1995): The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 270: 52-61.
9. Klune JR, Dhupar R, Cardinal J, et al. (2008): HMGB1: Endogenous danger signaling. Mol Med 14: 476-484.
10. Leon LR (2002): Invited review: Cytokine regulation of fever: studies using gene knockout mice. J Appl Physiol (1985) 92: 2648-2655.
11. Wrotek S, Jedrzejewski T, Piotrowski J, Kozak W (2016): N-Acetyl-l-cysteine exacerbates generation of IL-10 in cells stimulated with endotoxin in vitro and produces antipyresis via IL-10dependent pathway in vivo. Imm Lett 177: 1-5.
12. Erlandsson HH, Andersson U (2004): Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator. Eur J Immunol 34: 1503-1512.
13. Chen XL, Sun L, Guo F, et al. (2012): High-mobility group box-1 induces proinflammatory cytokines production of Kupffer cells through TLRs-dependent signaling pathway after burn injury. PLoS One 7: e50668.
14. Jaulmes A, Thierry S, Janvier B, et al. (2006): Activation of sPLA2-IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1beta. FASEB J 20: 1727-1729.
15. Leclerc P, Wähämaa H, Idborg H, et al. (2013): IL-1β/HMGB1 complexes promote The PGE2 biosynthesis pathway in synovial fibroblasts. Scand J Immunol 77: 350-360.
16. Derijk RH, Strijbos PJ, van Rooijen N, et al. (1993): Fever and thermogenesis in response to bacterial endotoxin involve macrophage-dependent mechanisms in rats. Am J Physiol 265: R1179-1183.
17. Hreggvidsdottir HS, Ostberg T, Wähämaa H, et al. (2009): The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J Leukoc Biol 86: 655-662.
18. Wähämaa H, Schierbeck H, Hreggvidsdottir HS, et al. (2011): High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts. Arthritis Res Ther 13: 136.
19. He Q, You H, Li XM, et al. (2012): HMGB1 promotes the synthesis of pro-IL-1β and pro-IL-18 by activation of p38 MAPK and NF-κB through receptors for advanced glycation end-products in macrophages. Asian Pac J Cancer Prev 13: 1365-1370.
20. Fang F, Jiang D (2016): IL-1β/HMGB1 signalling promotes the inflammatory cytokines release via TLR signalling in human intervertebral disc cells. Biosci 16: e00379.
21. Kozak W, Wrotek S, Walentynowicz K, Waszak P (2006): Fever and symptoms of sickness are present in mice lacking functional B and T lymphocytes. Acta Biologica Cracoviensia 48: 2-20.
22. Deng H, Maitra U, Morris M, Li L (2012): Molecular mechanism responsible for the priming of macrophage activation. J Biol Chem 288: 3897-3906.
23. Hayes MP, Zoon KC (1993): Priming of human monocytes for enhanced lipopolysaccharide responses: expression of alpha interferon, interferon regulatory factors, and tumor necrosis factor. Infect Immun 61: 3222-3227.
24. Bianchi ME (2009): HMGB1 loves company. J Leukoc Biol 86: 573-576.
Copyright: © 2024 Polish Society of Experimental and Clinical Immunology This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.